BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33293671)

  • 21. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
    Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
    Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
    Phernambucq EC; Spoelstra FO; Paul MA; Senan S; Melissant CF; Postmus PE; Smit EF
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1052-7. PubMed ID: 19616442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer.
    Bao Y; Peng F; Zhou QC; Yu ZH; Li JC; Cheng ZB; Chen L; Hu X; Chen YY; Wang J; Wang Y; Ma HL; Xu ZM; Lu RB; Deng XW; Chen M
    Radiother Oncol; 2015 Feb; 114(2):161-6. PubMed ID: 25497558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
    J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.
    Phernambucq EC; Palma DA; Vincent A; Smit EF; Senan S
    Lung Cancer; 2011 Dec; 74(3):451-6. PubMed ID: 21664713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
    Sampath S; Hall M; Schultheiss TE
    Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity.
    Phernambucq ECJ; Spoelstra FOB; Verbakel WFAR; Postmus PE; Melissant CF; Maassen van den Brink KI; Frings V; van de Ven PM; Smit EF; Senan S
    Ann Oncol; 2011 Jan; 22(1):132-138. PubMed ID: 20595452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
    Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
    J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer.
    Verma V; Moreno AC; Haque W; Fang P; Lin SH
    J Natl Compr Canc Netw; 2018 May; 16(5):508-516. PubMed ID: 29752325
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):841-8. PubMed ID: 17565244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.
    Thatcher N; Faivre-Finn C; Blackhall F; Anderson H; Lorigan P
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5051s-5056s. PubMed ID: 16000613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.
    Liew MS; Sia J; Starmans MH; Tafreshi A; Harris S; Feigen M; White S; Zimet A; Lambin P; Boutros PC; Mitchell P; John T
    Cancer Med; 2013 Dec; 2(6):916-24. PubMed ID: 24403265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
    Lu C; Lee JJ; Komaki R; Herbst RS; Feng L; Evans WK; Choy H; Desjardins P; Esparaz BT; Truong MT; Saxman S; Kelaghan J; Bleyer A; Fisch MJ
    J Natl Cancer Inst; 2010 Jun; 102(12):859-65. PubMed ID: 20505152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
    Rosenman JG; Halle JS; Socinski MA; Deschesne K; Moore DT; Johnson H; Fraser R; Morris DE
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):348-56. PubMed ID: 12243807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.
    Ramella S; Maranzano E; Frata P; Mantovani C; Lazzari G; Menichelli C; Navarria P; Pergolizzi S; Salvi F
    Tumori; 2012; 98(1):66-78. PubMed ID: 22495704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.